References
- Unger S, Scherer G, Superti-Furga A. Campomelic dysplasia. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, et al., editors. GeneReviews. Seattle: University of Washington, 1993. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1760/.
- Mansour S, Hall CM, Pembrey ME, Young ID. A clinical and genetic study of campomelic dysplasia. J Med Genet 1995; 32:415-20. https://doi.org/10.1136/jmg.32.6.415
- Symon A, Harley V. SOX9: a genomic view of tissue specific expression and action. Int J Biochem Cell Biol 2017;87:18-22. https://doi.org/10.1016/j.biocel.2017.03.005
- Foster JW, Dominguez-Steglich MA, Guioli S, Kwok C, Weller PA, Stevanovic M, et al. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 1994;372:525-30. https://doi.org/10.1038/372525a0
- Kwok C, Weller PA, Guioli S, Foster JW, Mansour S, Zuffardi O, et al. Mutations in SOX9, the gene responsible for Campomelic dysplasia and autosomal sex reversal. Am J Hum Genet 1995; 57:1028-36.
- Hattori T, Muller C, Gebhard S, Bauer E, Pausch F, Schlund B, et al. SOX9 is a major negative regulator of cartilage vascularization, bone marrow formation and endochondral ossification. Development 2010;137:901-11. https://doi.org/10.1242/dev.045203
- Lefebvre V, Huang W, Harley VR, Goodfellow PN, de Crom brugghe B. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol 1997;17:2336-46. https://doi.org/10.1128/MCB.17.4.2336
- Bell DM, Leung KK, Wheatley SC, Ng LJ, Zhou S, Ling KW, et al. SOX9 directly regulates the type-II collagen gene. Nat Genet 1997;16:174-8. https://doi.org/10.1038/ng0697-174
- Kent J, Wheatley SC, Andrews JE, Sinclair AH, Koopman P. A male-specific role for SOX9 in vertebrate sex determination. Development 1996;122:2813-22. https://doi.org/10.1242/dev.122.9.2813
- Bernard P, Tang P, Liu S, Dewing P, Harley VR, Vilain E. Dimerization of SOX9 is required for chondrogenesis, but not for sex determination. Hum Mol Genet 2003;12:1755-65. https://doi.org/10.1093/hmg/ddg182
- Kim HY, Yoon CH, Kim GH, Yoo HW, Lee BS, Kim KS, et al. A case of campomelic dysplasia without sex reversal. J Korean Med Sci 2011;26:143-5. https://doi.org/10.3346/jkms.2011.26.1.143
- Ko JM, Hah JH, Kim SW, Cho TJ, Kim GH, Yoo HW. A Korean girl with campomelic dysplasia caused by a novel nonsense mutation within the SOX9 gene. J Genet Med 2012;9:89-92. https://doi.org/10.5734/JGM.2012.9.2.89
- Meyer J, Sudbeck P, Held M, Wagner T, Schmitz ML, Bricarelli FD, et al. Mutational analysis of the SOX9 gene in campomelic dysplasia and autosomal sex reversal: lack of genotype/phenotype correlations. Hum Mol Genet 1997;6:91-8. https://doi.org/10.1093/hmg/6.1.91
- Mansour S, Offiah AC, McDowall S, Sim P, Tolmie J, Hall C. The phenotype of survivors of campomelic dysplasia. J Med Genet 2002;39:597-602. https://doi.org/10.1136/jmg.39.8.597
- Pfeifer D, Kist R, Dewar K, Devon K, Lander ES, Birren B, et al. Campomelic dysplasia translocation breakpoints are scattered over 1 Mb proximal to SOX9: evidence for an extended control region. Am J Hum Genet 1999;65:111-24. https://doi.org/10.1086/302455